Real-time enrollment status for this recurrent ovarian high grade serous adenocarcinoma clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 11:07 PM UTC
| NCT Number | NCT04633239 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Ovarian High Grade Serous Adenocarcinoma |
| Phase | PHASE1 |
| Target Enrollment | 42 participants |
| Active Locations | 27 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | September 11, 2026 (Sep 11, 2026) |
As of October 21, 2026: Clinical trial NCT04633239 is currently recruiting participants. This phase1 study for recurrent ovarian high grade serous adenocarcinoma is actively seeking new participants at 27 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04633239 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 27 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04633239 was last updated Sep 11, 2026 (September 11, 2026). HelloStudys verifies this status automatically.